Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Bausch Health Companies Inc. |
| Cipher Pharmaceuticals Inc. |
| Knight Therapeutics Inc. |
| Merck & Co., Inc. |
| AstraZeneca PLC |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| BHC | CPH | GUD | MRK | AZN1 N | HLTR.F | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 4% | 13% | 1% | 41% | 18% | -23% | ||
| Fiscal Year - 1 | 69% | 28% | -2% | 1% | 16% | -25% | ||
| Fiscal Year - 2 | 56% | 52% | -4% | 34% | 9% | -16% | ||
| Fiscal Year - 3 | -442% | 22% | 2% | 39% | 0% | -8% | ||
| Fiscal Year - 4 | -70% | 14% | 5% | 18% | 22% | -9% | ||
| Fiscal Year - 5 | -94% | 10% | 2% | 22% | 10% | -12% | ||
| Average | -79% | 23% | 1% | 26% | 12% | -15% | ||
| Median | -33% | 18% | 1% | 28% | 13% | -14% | ||
| Benchmarks | Ticker | |||||||
| Bausch Health Companies Inc. | TSX:BHC | |||||||
| Cipher Pharmaceuticals Inc. | TSX:CPH | |||||||
| Knight Therapeutics Inc. | TSX:GUD | |||||||
| Merck & Co., Inc. | NEOE:MRK | |||||||
| AstraZeneca PLC | BMV:AZN1N | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | BHC | CPH | GUD | MRK | AZN1 N | HLTR.F | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 9,625 | 33 | 371 | 64,168 | 54,073 | 57 | ||
| Fiscal Year | 9,625 | 33 | 371 | 64,168 | 54,073 | 57 | ||
| Fiscal Year - 1 | 8,757 | 21 | 328 | 60,115 | 45,811 | 63 | ||
| Fiscal Year - 2 | 8,124 | 21 | 294 | 59,283 | 44,351 | 61 | ||
| Fiscal Year - 3 | 8,434 | 22 | 243 | 48,704 | 37,417 | 60 | ||
| Fiscal Year - 4 | 8,027 | 22 | 200 | 41,518 | 26,617 | 56 | ||
| Fiscal Year - 5 | 8,601 | 22 | 47 | 39,121 | 24,384 | 54 | ||
| Net Income | ||||||||
| Latest Twelve Months | (46) | 12 | 4 | 17,117 | 7,035 | (20) | ||
| Fiscal Year | (46) | 12 | 4 | 17,117 | 7,035 | (20) | ||
| Fiscal Year - 1 | (592) | 20 | (17) | 365 | 5,955 | (28) | ||
| Fiscal Year - 2 | (225) | 27 | (30) | 14,519 | 3,288 | (24) | ||
| Fiscal Year - 3 | (948) | 8 | 16 | 12,345 | 112 | (13) | ||
| Fiscal Year - 4 | (560) | 4 | 42 | 4,519 | 3,196 | (15) | ||
| Fiscal Year - 5 | (1,788) | 3 | 15 | 5,690 | 1,335 | (20) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 27,350 | 86 | 945 | 106,675 | 101,119 | 209 | ||
| Latest Fiscal Quarter | 26,523 | 163 | 964 | 117,106 | 104,035 | 160 | ||
| Fiscal Year | 26,523 | 163 | 964 | 117,106 | 104,035 | 160 | ||
| Fiscal Year - 1 | 27,350 | 86 | 945 | 106,675 | 101,119 | 209 | ||
| Fiscal Year - 2 | 25,686 | 74 | 1,055 | 109,160 | 96,483 | 242 | ||
| Fiscal Year - 3 | 29,202 | 52 | 992 | 105,694 | 105,363 | 276 | ||
| Fiscal Year - 4 | 31,199 | 44 | 1,040 | 91,588 | 66,729 | 304 | ||
| Fiscal Year - 5 | 33,863 | 46 | 1,305 | 84,397 | 61,377 | 320 | ||
| Fiscal Year - 6 | 32,492 | 56 | 1,052 | 82,637 | 60,651 | 306 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | (1,022) | 81 | 747 | 37,581 | 39,143 | 98 | ||
| Latest Fiscal Quarter | (1,279) | 102 | 795 | 46,313 | 40,786 | 71 | ||
| Fiscal Year | (1,279) | 102 | 795 | 46,313 | 40,786 | 71 | ||
| Fiscal Year - 1 | (1,022) | 81 | 747 | 37,581 | 39,143 | 98 | ||
| Fiscal Year - 2 | (692) | 64 | 826 | 45,991 | 37,037 | 125 | ||
| Fiscal Year - 3 | (106) | 39 | 842 | 38,184 | 39,268 | 161 | ||
| Fiscal Year - 4 | 535 | 33 | 886 | 25,317 | 15,622 | 169 | ||
| Fiscal Year - 5 | 1,063 | 28 | 811 | 25,907 | 13,127 | 178 | ||
| Fiscal Year - 6 | 2,733 | 25 | 1,030 | 26,701 | 12,468 | 158 | ||